Draflazine
Modify Date: 2025-08-25 18:44:49
Draflazine structure
|
Common Name | Draflazine | ||
|---|---|---|---|---|
| CAS Number | 120770-34-5 | Molecular Weight | 604.51800 | |
| Density | 1.338g/cm3 | Boiling Point | 755.9ºC at 760mmHg | |
| Molecular Formula | C30H33Cl2F2N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 411ºC | |
Use of DraflazineDraflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freund’s adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia[1]. |
| Name | 1-[2-(4-amino-2,6-dichloroanilino)-2-oxoethyl]-4-[5,5-bis(4-fluorophenyl)pentyl]piperazine-2-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freund’s adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia[1]. |
|---|---|
| Related Catalog | |
| Target |
ENT1[1] |
| References |
| Density | 1.338g/cm3 |
|---|---|
| Boiling Point | 755.9ºC at 760mmHg |
| Molecular Formula | C30H33Cl2F2N5O2 |
| Molecular Weight | 604.51800 |
| Flash Point | 411ºC |
| Exact Mass | 603.19800 |
| PSA | 104.69000 |
| LogP | 6.49650 |
| Vapour Pressure | 9.69E-23mmHg at 25°C |
| Index of Refraction | 1.618 |
| Draflazine |
| Draflazinum |
| Draflazina |